[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This will be an open, single-arm, international, multicentre, phase II imaging study to
assess the predictive value of [68Ga]Ga PentixaFor PET imaging in primary and isolated
secondary central nervous system lymphoma (CNSL) patients scheduled to undergo induction
chemotherapy.